Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Februar 2019 08:09 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Receives Tremendous Response for CEO’s Personal Shareholder Loyalty Gift; Planning Underway for the Company’s 2019 Black-Tie Dinner Awards Gala Presentations

IRVINE, CA, Feb. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it...
23. Januar 2019 09:38 ET | Quelle: Cannabis Science, Inc.

Overwhelming CBIS Shareholder Responses Prompts RCD to Choose www.iCannabinoid.com to Interact and Inform on All Company Projects, Drug Development, and All RCD Initiatives

IRVINE, CA , Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that...
14. Januar 2019 11:26 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Receives Overwhelming Response From Mr. Raymond C. Dabney’s Shareholder Loyalty Gift Package; Get Set for Cannabis Science 2019 Black-Tie Dinner Awards Gala

IRVINE, CA, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces it is...
24. Dezember 2018 08:54 ET | Quelle: Cannabis Science, Inc.

CBIS Celebrates U.S. Congress Passage of the 2018 Farm Bill and RCD Welcomes All Shareholders to the Loyalty Gift Final

IRVINE, CA, Dec. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, applauds the U.S....
21. November 2018 12:33 ET | Quelle: Cannabis Science, Inc.

The Cannabis Science Inaugural Black-Tie Awards Gala Final Planning Underway; Recognizing Major Industry Accomplishments, Killing Cancer, and Awarding Unprecedented Shareholder Loyalty

IRVINE, Calif., Nov. 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Cannabis Science, Inc. (USOTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased...
21. November 2018 08:28 ET | Quelle: Cannabis Science, Inc.

The Cannabis Science Inaugural Black-Tie Dinner Awards Gala Final Planning Underway; Recognizing Major Industry Accomplishments, Killing Cancer, and Awarding Unprecedented Shareholder Loyalty

IRVINE, CA, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
29. Oktober 2018 09:01 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Confirms Receipt of Issued US Patent Number 9,763,991 For Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, Sleep Deprivation (Insomnia), Anxiety Disorders (ADHD), and (PTSD)

IRVINE, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
24. Oktober 2018 08:03 ET | Quelle: Cannabis Science, Inc.

CBIS Re-Appoints Mr. Melvin Foote to Its International Government Affairs Board; Mr. Foote Will Continue to Counsel CBIS as South African Cannabinoid Clinical Studies are Underway

IRVINE, CA, Oct. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
01. Oktober 2018 08:12 ET | Quelle: Cannabis Science, Inc.

UPDATE: Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board (IGAB)

IRVINE, CA, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
28. September 2018 07:40 ET | Quelle: Cannabis Science, Inc.

Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board

IRVINE, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...

Vorherige Seite

Nächste Seite